Avalyn Pharma
Latest round
- Series D
Last raised
- Jul 2025
Total raised
- $387M
Investors
- 19
About Avalyn Pharma
Avalyn Pharma Inc.Avalyn Pharma Inc. was founded in 2011 and is headquartered in Seattle, US. The company specializes in developing targeted therapies for rare respiratory conditions. In July 2025, Avalyn Pharma Inc. Avalyn Pharma Inc. develops targeted inhaled therapies for rare respiratory diseases, concentrating on pulmonary fibrosis and interstitial lung diseases. Its core products include AP01, an inhaled formulation of pirfenidone, and AP02, an inhaled version of nintedanib.Avalyn Pharma Inc. generates revenue through partnerships with healthcare providers, focusing on the sale of its inhaled drug products. The company enters agreements with hospitals and specialized clinics for the administration of its inhaled therapies for pulmonary fibrosis, often including provisions for bulk purchases or exclusive supply contracts. Its flagship products, AP01 and AP02, form the foundation of its revenue model, with pricing aligned to therapeutic value and clinical outcomes.
Who invested in Avalyn Pharma
19 investors across 4 rounds
See all investors in Avalyn Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avalyn Pharma
Who invested in Avalyn Pharma?
Avalyn Pharma has 19 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avalyn Pharma raised?
Avalyn Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Avalyn Pharma last raise money?
Avalyn Pharma's most recent round on record is a Series D, in Jul 2025.
What does Avalyn Pharma do?
Avalyn Pharma is a biotechnology company.
Where is Avalyn Pharma headquartered?
Avalyn Pharma is headquartered in Cambridge, US.
Which VCs invest in companies like Avalyn Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avalyn Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Avalyn Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.